What is the stock price of BLACKROCK SCIENCE & TECH TR today?

The current stock price of BST is 40.88 USD . The price increased by 0.42% in the last trading session.

What is the ticker symbol for BLACKROCK SCIENCE & TECH TR stock?

The exchange symbol of BLACKROCK SCIENCE & TECH TR is BST and it is listed on the New York Stock Exchange, Inc. exchange.

On which exchange is BST stock listed?

BST stock is listed on the New York Stock Exchange, Inc. exchange.

BST Stock Price - BLACKROCK SCIENCE & TECH TR Stock Price, News and Analysis

Fundamental Rating

Overall BST gets a fundamental rating of 2 out of 10. We evaluated BST against 0 industry peers in the Unkown industry. BST has a bad profitability rating. Also its financial health evaluation is rather negative. BST has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year BST was profitable.

In the past year BST had a positive cash flow from operations.

BST had positive earnings in 4 of the past 5 years.

In multiple years BST reported negative operating cash flow during the last 5 years.

1.2 Ratios

		Industry Rank	Sector Rank
ROA	19.67%
ROE	19.85%
ROIC	N/A

ROA(3y)-8.09%

ROA(5y)4.63%

ROE(3y)-8.04%

ROE(5y)4.83%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

In the last couple of years the Profit Margin of BST has declined.

BST does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	6500%
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y17.43%

PM growth 5Y-3.35%

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

Compared to 1 year ago, BST has more shares outstanding

BST has more shares outstanding than it did 5 years ago.

BST has a better debt/assets ratio than last year.

2.2 Solvency

BST has an Altman-Z score of 65.87. This indicates that BST is financially healthy and has little risk of bankruptcy at the moment.

BST has a debt to FCF ratio of 0.01. This is a very positive value and a sign of high solvency as it would only need 0.01 years to pay back of all of its debts.

BST has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.

Although BST does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0.01
Altman-Z	65.87

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

BST has a Current Ratio of 0.09. This is a bad value and indicates that BST is not financially healthy enough and could expect problems in meeting its short term obligations.

A Quick Ratio of 0.09 indicates that BST may have some problems paying its short term obligations.

		Industry Rank	Sector Rank
Current Ratio	0.09
Quick Ratio	0.09

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for BST have decreased by -8.02% in the last year.

BST shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -3.82% yearly.

Looking at the last year, BST shows a decrease in Revenue. The Revenue has decreased by -3.21% in the last year.

The Revenue has been growing by 8.06% on average over the past years. This is quite good.

EPS 1Y (TTM)-8.02%

EPS 3Y22.37%

EPS 5Y-3.82%

EPS Q2Q%6.28%

Revenue 1Y (TTM)-3.21%

Revenue growth 3Y7.3%

Revenue growth 5Y8.06%

Sales Q2Q%17.09%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 5.24, which indicates a rather cheap valuation of BST.

Compared to an average S&P500 Price/Earnings ratio of 27.30, BST is valued rather cheaply.

		Industry Rank	Sector Rank
PE	5.24
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	15.1
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.58%, BST is a good candidate for dividend investing.

BST's Dividend Yield is rather good when compared to the S&P500 average which is at 2.45.

		Industry Rank	Sector Rank
Dividend Yield	7.58%

5.2 History

The dividend of BST decreases each year by -1.74%.

BST has paid a dividend for at least 10 years, which is a reliable track record.

BST has decreased its dividend in the last 3 years.

Dividend Growth(5Y)-1.74%

Div Incr Years0

Div Non Decr Years2

5.3 Sustainability

BST pays out 37.36% of its income as dividend. This is a sustainable payout ratio.

The Dividend Rate of BST has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.

DP37.36%

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

BLACKROCK SCIENCE & TECH TR

NYSE:BST (9/12/2025, 8:04:01 PM)

After market: 39.2188 -1.66 (-4.06%)

40.88

+0.17 (+0.42%)

Chartmill FA Rating

GICS SectorN/A

GICS IndustryGroupN/A

GICS IndustryN/A

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners19.46%

Inst Owner Change2.01%

Ins Owners0%

Ins Owner Change0%

Market Cap1.42B

Analysts0

Price TargetN/A

Short Float %0.14%

Short Ratio0.49

Dividend

		Industry Rank	Sector Rank
Dividend Yield	7.58%

Yearly Dividend2.96

Dividend Growth(5Y)-1.74%

DP37.36%

Div Incr Years0

Div Non Decr Years2

Ex-Date08-15 2025-08-15 (0.25)

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	5.24
Fwd PE	N/A
P/S	337.94
P/FCF	15.1
P/OCF	15.1
P/B	1.03
P/tB	1.03
EV/EBITDA	N/A

EPS(TTM)7.8

EY19.08%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)2.71

FCFY6.62%

OCF(TTM)2.71

OCFY6.62%

SpS0.12

BVpS39.6

TBVpS39.6

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	19.67%
ROE	19.85%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	6500%
GM	N/A
FCFM	2238.1%

ROA(3y)-8.09%

ROA(5y)4.63%

ROE(3y)-8.04%

ROE(5y)4.83%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y17.43%

PM growth 5Y-3.35%

GM growth 3YN/A

GM growth 5YN/A

F-Score3

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0.01
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	34.43%
Current Ratio	0.09
Quick Ratio	0.09
Altman-Z	65.87

F-Score3

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-8.02%

EPS 3Y22.37%

EPS 5Y-3.82%

EPS Q2Q%6.28%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-3.21%

Revenue growth 3Y7.3%

Revenue growth 5Y8.06%

Sales Q2Q%17.09%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-25.85%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y80.77%

FCF growth 3YN/A

FCF growth 5Y6.67%

OCF growth 1Y80.77%

OCF growth 3YN/A

OCF growth 5Y6.67%

BLACKROCK SCIENCE & TECH TR (BST) Stock Overview

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens